David Bertwistle
Impact in
- Oncology top 5%
- Cancer-related Molecular Pathways
- PARP inhibition in cancer therapy
- Molecular Biology top 5%
- DNA Repair Mechanisms
- CRISPR and Genetic Engineering
- Ubiquitin and proteasome pathways
- RNA modifications and cancer
- Genomics and Chromatin Dynamics
Papers in
-
- DNA Repair Mechanisms 10
- Epigenetics and DNA Methylation 4
- CRISPR and Genetic Engineering 4
- Congenital heart defects research 3
- Genetics 11
- BRCA gene mutations in cancer 9
- Co-authors
- Alan Ashworth (8 shared papers)Charles J. Sherr (5 shared papers)Masataka Sugimoto (2 shared papers)Sally Swift (2 shared papers)Frances Connor (2 shared papers)Andrew Tutt (3 shared papers)Anastasia Gabriel (2 shared papers)Gillian Ross (2 shared papers)
- Journals
- Value in Health (5 papers)Journal of Clinical Oncology (4 papers)Breast Cancer Research (4 papers)The EMBO Journal (3 papers)Current Biology (2 papers)
- Partner nations
- United KingdomUnited StatesNetherlands
In The Last Decade
David Bertwistle
41 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 75
- Oncology 677
- Molecular Biology 1.8k
- Genetics 665
- Cancer Research 279
- Cell Biology 274
Countries citing papers authored by David Bertwistle
This map shows the geographic impact of David Bertwistle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Bertwistle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Bertwistle more than expected).
Fields of papers citing papers by David Bertwistle
This network shows the impact of papers produced by David Bertwistle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Bertwistle. The network helps show where David Bertwistle may publish in the future.
Co-authors
The 25 scholars most cited alongside David Bertwistle, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1997 | 346 | |
| 2 | 2001 | 344 | |
| 3 | 2004 | 322 | |
| 4 | 1999 | 264 | |
| 5 | 2004 | 172 | |
| 6 | 1999 | 156 | |
| 7 | Nuclear location and cell cycle regulation of the BRCA2 protein. | 1997 | 91 |
| 8 | 1994 | 89 | |
| 9 | 2005 | 84 | |
| 10 | 1998 | 84 | |
| 11 | 2005 | 42 | |
| 12 | 1996 | 40 | |
| 13 | 1997 | 24 | |
| 14 | 2004 | 24 | |
| 15 | 2003 | 23 | |
| 16 | 1999 | 16 | |
| 17 | 2006 | 14 | |
| 18 | 2002 | 14 | |
| 19 | 2022 | 10 | |
| 20 | 2020 | 9 |
About David Bertwistle
David Bertwistle is a scholar working on Molecular Biology, Genetics, Surgery, Oncology and Pulmonary and Respiratory Medicine, having authored 42 papers that have together received 2.2k indexed citations. Recurring topics across this work include DNA Repair Mechanisms (10 papers), BRCA gene mutations in cancer (9 papers), Esophageal Cancer Research and Treatment (9 papers), Gastric Cancer Management and Outcomes (7 papers), Cancer-related Molecular Pathways (6 papers), Epigenetics and DNA Methylation (4 papers), CRISPR and Genetic Engineering (4 papers) and Congenital heart defects research (3 papers). The work is most often cited by research in Oncology (677 citations), Molecular Biology (1.8k citations), Genetics (665 citations), Cancer Research (279 citations) and Cell Biology (274 citations). David Bertwistle has collaborated with scholars based in United Kingdom, United States and Netherlands. Frequent co-authors include Alan Ashworth, Charles J. Sherr, Masataka Sugimoto, Sally Swift, Frances Connor, Andrew Tutt, Anastasia Gabriel, Gillian Ross, Martine F. Roussel and Willem den Besten. Their work appears in journals such as Value in Health, Journal of Clinical Oncology, Breast Cancer Research, The EMBO Journal and Current Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.